This Phase III COBRE application seeks to support and sustain the momentum achieved during developmental Phases I and II of the Center for Colon Cancer Research (CCCR) at the University of South Carolina. In the US and South Carolina, colorectal cancer remains the 2nd leading cause of cancer death and the 4th highest in incidence. In the 91/2 years since COBRE funding was initiated, the CCCR has made significant strides in enhancing the critical mass of independent scientists studying this disease, as judged by establishment of fully functional laboratories, receipt of extramural research grants, and publication in highly regarded, peer-reviewed journals. In addition, a vibrant outreach program has been designed and implemented to educate citizens from diverse economic backgrounds about colorectal cancer and the value of screening, making South Carolina a national leader in advocacy for this disease. The CCCR is now a fully established, self-standing center that contributes to the nation's goal of reducing the morbidity of colorectal cancer. To carry on with this effort, the CCCR will implement the following aims during Phase III: Provision of administrative services and support through the Administrative Core. Support of financial, programmatic, and training aspects of the CCCR research and outreach effort will be provided. Operation of a group of interactive Research Cores. CCCR investigators will have state-of-the-art expertise and technology available through four Cores, each of which is led by an experienced and knowledgeable member of the CCCR faculty. Oversight of a Research Pilot Project Program. Through fiscal support for development of investigator initiated seed projects, as well as development of multi-disciplinary programs, the Pilot Project effort will enable entry into challenging new research areas, and will mediate unique collaborations. In addition, the project will manage a graduate scholarship program for underserved minorities. In all, the wide range of knowledge and proficiency exhibited by the interdisciplinary faculty comprising the CCCR provides the basis for sustaining, during Phase III period, that which was built during Phases I and II.

Public Health Relevance

Colorectal cancer is diagnosed in over 140,000 Americans each year, and takes 51,000 lives. There is need for focused research on this disease in order to identify and implement improved strategies for diagnosing, preventing, and treating it. Such is the goal of the Center for Colon Cancer Research at the University of South Carolina.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1-TWD-C (C3))
Program Officer
Gorospe, Rafael
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of South Carolina at Columbia
Schools of Arts and Sciences
United States
Zip Code
Farmaki, E; Chatzistamou, I; Kaza, V et al. (2016) A CCL8 gradient drives breast cancer cell dissemination. Oncogene 35:6309-6318
Peña, Edsel A; Wu, Wensong; Piegorsch, Walter et al. (2016) Model Selection and Estimation with Quantal-Response Data in Benchmark Risk Assessment. Risk Anal :
Kindo, Bereket P; Wang, Hao; Peña, Edsel A (2016) Multinomial probit Bayesian additive regression trees. Stat (Int Stat Inst) 5:119-131
Wallace, Kristin; Brandt, Heather M; Bearden, James D et al. (2016) Race and Prevalence of Large Bowel Polyps Among the Low-Income and Uninsured in South Carolina. Dig Dis Sci 61:265-72
Watson, Shana R; Liu, Piaomu; Peña, Edsel A et al. (2016) Comparison of Aortic Collagen Fiber Angle Distribution in Mouse Models of Atherosclerosis Using Second-Harmonic Generation (SHG) Microscopy. Microsc Microanal 22:55-62
Jung, Joo-Yong; Gleave Parson, Madeline; Kraft, Jennifer D et al. (2016) Elevated interleukin-27 levels in human neonatal macrophages regulate indoleamine dioxygenase in a STAT-1 and STAT-3-dependent manner. Immunology 149:35-47
Patel, Yogin; Shah, Nirav; Lee, Ji Shin et al. (2016) A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth. Oncotarget 7:18295-308
Chatzistamou, Ioulia; Kiaris, Hippokratis (2016) Modeling estrogen receptor-positive breast cancers in mice: is it the best we can do? Endocr Relat Cancer 23:C9-C12
Broude, Eugenia V; Győrffy, Balázs; Chumanevich, Alexander A et al. (2015) Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer. Curr Cancer Drug Targets 15:739-49
Levina, Elina; Ji, Hao; Chen, Mengqiang et al. (2015) Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells. Oncotarget 6:13088-104

Showing the most recent 10 out of 20 publications